10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 28, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 186,519 | 176,594 | 172,310 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (148,821) | (146,469) | (140,312) |
| Insurance benefits paid | (7,057) | (2,810) | (2,199) |
| Cash paid to other suppliers and employees | (17,234) | (15,348) | (15,478) |
| Interest and investment income received | 644 | 21 | 20 |
| Interest paid | (2,803) | (1,072) | (1,140) |
| Income taxes paid | (2,383) | (2,909) | (3,060) |
| Net cash provided by operating activities | 8,865 | 8,007 | 10,141 |
| Cash flows from investing activities: | |||
| Proceeds from sales and maturities of investments | 817 | 61 | 91 |
| Purchases of investments | (692) | (137) | (80) |
| Purchases of property and equipment | (2,037) | (1,918) | (2,224) |
| Proceeds from sale-leaseback transactions | 0 | 265 | 230 |
| Acquisitions (net of cash acquired) | (42,226) | (1,181) | (524) |
| Proceeds from sale of subsidiary and other assets | 832 | 0 | 0 |
| Other | 21 | 33 | 37 |
| Net cash used in investing activities | (43,285) | (2,877) | (2,470) |
| Cash flows from financing activities: | |||
| Net repayments of short-term debt | (556) | (598) | 1,874 |
| Proceeds from issuance of long-term debt | 44,343 | 0 | 3,455 |
| Repayments of long-term debt | (5,522) | 0 | (5,943) |
| Purchase of noncontrolling interest in subsidiary | 0 | 0 | (39) |
| Payment of contingent consideration | 0 | 0 | (26) |
| Derivative settlements | 446 | 0 | 0 |
| Repurchase of common stock | 0 | (4,361) | (4,461) |
| Dividends paid | (2,038) | (2,049) | (1,840) |
| Proceeds from exercise of stock options | 242 | 329 | 296 |
| Payments for taxes related to net share settlement of equity awards | (97) | (71) | (72) |
| Other | 1 | (1) | (5) |
| Net cash provided by (used in) financing activities | 36,819 | (6,751) | (6,761) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (4) | 1 | 2 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 2,395 | (1,620) | 912 |
| Cash, cash equivalents and restricted cash at the end of the period | 1,900 | 3,520 | |
| Cash, cash equivalents and restricted cash at the end of the period | 4,295 | 1,900 | 3,520 |
| Reconciliation of net income (loss) to net cash provided by operating activities: | |||
| Net income (loss) | (596) | 6,623 | 5,319 |
| Reconciliation of net loss to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,718 | 2,479 | 2,475 |
| Goodwill impairments | 6,149 | 181 | 0 |
| Losses on settlements of defined benefit pension plans | 0 | 187 | 0 |
| Stock-based compensation | 280 | 234 | 222 |
| Loss on early extinguishment of debt | 0 | 0 | 643 |
| Deferred income taxes | 87 | (1,334) | 18 |
| Other noncash items | 339 | 53 | 135 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (1,139) | (941) | (243) |
| Inventories | (1,153) | (514) | (742) |
| Other assets | (3) | (338) | (8) |
| Accounts payable and pharmacy claims and discounts payable | 2,489 | 1,710 | 2,189 |
| Health care costs payable and other insurance liabilities | (471) | 0 | (19) |
| Other liabilities | 165 | (333) | 152 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |